NCI Installs Site Licenses for Ariadne Pathway Studio and PathwayExpert
Complete the form below to unlock access to ALL audio articles.
Ariadne Genomics, Inc. has announced that it has licensed Pathway Studio and its Enterprise installation, PathwayExpert software to the National Cancer Institute (NCI) to be used for pathway and microarray data analysis with integrated literature mining.
The NCI has purchased site licenses of Ariadne pathway analysis software, together with the ResNet database making it available to every researcher at the NCI.
"We are honored that the National Cancer Institute has chosen Ariadne pathway software to facilitate its cancer target and biomarker research," said Ilya Mazo, President of Ariadne.
An important aspect of the decision is that Pathway Studio automatically updates the database, keeping the NCI users up-to-date while the user interface allows for expansion of known pathways and new regulatory networks reconstruction focused on specific research tasks.
Ariadne Pathway Studio software is designed to enable life scientists to identify relationships among proteins, small molecules, cell processes and treatments, and automatically extract relevant biological interactions from the scientific literature.
With the integral resident ResNet database of over 1,000,000 interactions extracted from PubMed and approximately 1000 predefined pathways, researchers can reconstruct signaling and regulatory networks from microarray and proteomics data, identify biomarkers, and model drug responses.
PathwayExpert is an Enterprise-scale web-based edition of Pathway Studio which contains advanced microarray data analysis tools and enables integration of data from different sources: Ariadne databases, public and customer-proprietary.
